Cargando…
Predicted Economic Benefits of a Novel Biomarker for Earlier Sepsis Identification and Treatment: A Counterfactual Analysis
To estimate the potential clinical and health economic value of earlier sepsis identification in the emergency department using a novel diagnostic marker, monocyte distribution width. DESIGN: The analysis was conducted in two phases: 1) an analysis of the pivotal registration trial evidence to estim...
Autores principales: | Paoli, Carly J., Reynolds, Mark A., Coles, Courtney, Gitlin, Matthew, Crouser, Elliott |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063955/ https://www.ncbi.nlm.nih.gov/pubmed/32166270 http://dx.doi.org/10.1097/CCE.0000000000000029 |
Ejemplares similares
-
Epidemiology and Costs of Sepsis in the United States—An Analysis Based on Timing of Diagnosis and Severity Level*
por: Paoli, Carly J., et al.
Publicado: (2018) -
The specter of irreparable ignorance: counterfactuals and causality in economics
por: DeMartino, George F.
Publicado: (2021) -
Counterfactual Desirability
por: Bradley, Richard, et al.
Publicado: (2017) -
Understanding Counterfactuality: A Review of Experimental Evidence for the Dual Meaning of Counterfactuals
por: Kulakova, Eugenia, et al.
Publicado: (2016) -
Causal conditionals and counterfactuals
por: Frosch, Caren A., et al.
Publicado: (2012)